Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 3Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Venous Thromboembolism 8Venous Thrombosis 6Neoplasms 6Pulmonary Embolism 5Thromboembolism 3Lung Neoplasms 3Multiple Myeloma 2Lymphoma 2Colorectal Neoplasms 2Vascular Diseases 1Urogenital Neoplasms 1Thrombosis 1Thrombocytopenia 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Myeloproliferative Disorders 1Lymphoproliferative Disorders 1Lymphatic Diseases 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Intestinal Neoplasms 1Hemostatic Disorders 1Hemorrhage 1Digestive System Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × Tinzaparin × Clear all
NCT03090880 2022-11-17

PROVE

Assistance Publique - Hôpitaux de Paris

Phase 3 Terminated
59 enrolled
Classical hematologyThoracic

Lung Neoplasms, Venous Thromboembolism

NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryLymphoidMyeloidOther hematologic neoplasmPlasma cellThoracic

Breast Neoplasms, Digestive System Neoplasms, Intestinal Neoplasms, Leukemia, Lung Neoplasms, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Multiple Myeloma, Myeloproliferative Disorders, Neoplasms, Prostatic Neoplasms, Thromboembolism, Urogenital Neoplasms, Vascular Diseases, Colorectal Neoplasms, Hemostatic Disorders, Venous Thrombosis, Venous Thromboembolism

NCT00475098 2016-09-02

TILT

Assistance Publique - Hôpitaux de Paris

Phase 3 Completed
553 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡